СОВРЕМЕННЫЕ ТЕНДЕНЦИИ ЗАБОЛЕВАЕМОСТИ ДЕРМАТОВЕНЕРОЛОГИЧЕСКИМИ БОЛЕЗНЯМИ В УСЛОВИЯХ МИГРАЦИОННЫХ ПРОЦЕССОВ
MODERN TRENDS IN THE INCIDENCE OF DERMATOVENEROLOGICAL DISEASES UNDER THE CONDITIONS OF MIGRATION PROCESSES
Main Article Content
Abstract
Relevance. Dermatovenerological diseases remain one of the most widespread groups of pathologies exerting a significant influence on the quality of life and social adaptation of patients. Under conditions of intensifying migration processes, the structure of morbidity, the clinical manifestations and the timeliness of diagnosis of skin and venereal diseases change, which increases the risk of complicated forms and hampers the organization of specialized medical care. Aim. To assess modern trends in morbidity and the structure of dermatovenerological diseases under conditions of migration, and also to identify the factors associated with late diagnosis and a complicated course. Materials and methods. An observational analytical study with retrospective and prospective components was carried out. The data of 150 patients with dermatological and venereological diseases were analysed, of whom 30 constituted the group of migrants and 120 the group of permanent residents of the region. The structure of morbidity, the frequency of infectious and non-infectious dermatoses and of sexually transmitted infections, the time of seeking care, and the prevalence of self-medication and of late diagnosis were assessed. Methods of descriptive and comparative statistics were used; differences were considered significant at p < 0.05. Results. In patients with migrant status, infectious dermatoses and sexually transmitted infections, including combined and complicated forms, were identified significantly more often. In this group a higher frequency of late presentation for medical care and of self-medication was noted, which was accompanied by an atypical clinical course, the need for extended laboratory examination and an increase in the duration of therapy. Chronic non-infectious inflammatory dermatoses predominated in the permanent residents of the region. Conclusion. Migrant status is a significant factor influencing the structure of dermatovenerological morbidity and the timeliness of diagnosis. The data obtained substantiate the need to optimize dermatovenerological care under conditions of high migration mobility of the population, with an emphasis on early detection, prevention and the accessibility of specialized medical care.
Article Details
Issue
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
World Health Organization. Global report on skin diseases. Geneva: WHO; 2023.
Hay R.J., Johns N.E., Williams H.C., et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527–1534.
Karimkhani C., Dellavalle R.P., Coffeng L.E., et al. Global skin disease morbidity and mortality: an update. Br J Dermatol. 2017;177(1):e17–e19.
World Health Organization. Global health sector strategy on sexually transmitted infections 2016–2025. Geneva: WHO; 2016.
Newman L., Rowley J., Vander Hoorn S., et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections. PLoS One. 2015;10(12):e0143304.
International Organization for Migration. World Migration Report 2022. Geneva: IOM; 2022.
United Nations Department of Economic and Social Affairs. International Migration Report 2023. New York: UN; 2023.
Marmot M., Allen J., Bell R., Bloomer E., Goldblatt P. WHO European review of social determinants of health and the health divide. Lancet. 2012;380(9846):1011–1029.
Castelli F., Sulis G. Migration and infectious diseases. Clin Microbiol Infect. 2017;23(5):283–289.
Heukelbach J., Feldmeier H. Scabies. Lancet. 2006;367(9524):1767–1774.
Hay R.J., Ashbee H.R. Fungal infections. In: Rook’s Textbook of Dermatology. 9th ed. Oxford: Wiley-Blackwell; 2016.
Bowen A.C., Mahé A., Hay R.J., et al. The global epidemiology of impetigo. Bull World Health Organ. 2015;93(11):739–740.
Norredam M., Nielsen S.S., Krasnik A. Migrants’ access to healthcare. Eur J Public Health. 2010;20(5):555–559.
Rechel B., Mladovsky P., Devillé W., et al. Migration and health in the European Union. Lancet. 2013;381(9873): 121–130.
Hacker K., Anies M., Folb B.L., Zallman L. Barriers to health care for undocumented immigrants. J Health Care Poor Underserved. 2015;26(4):1051–1067.
Goldenberg S.M., Strathdee S.A., Perez-Rosales M.D., Sued O. Mobility and HIV vulnerability. AIDS Behav. 2012;16(8):1994–2003.
Decker M.R., Wirtz A.L., Baral S.D., et al. Injection drug use, sexual risk, violence and STI among migrants. Lancet. 2014;385(9964):55–64.
European Centre for Disease Prevention and Control. STI surveillance in Europe 2022. Stockholm: ECDC; 2022.
Janier M., Lassau F., Casin I., Morel P. Atypical presentations of sexually transmitted infections. Clin Dermatol. 2014;32(2):223–232.
Cohen M.S., Hoffman I.F., Royce R.A., et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis. Lancet. 1997;349(9069):1868–1873.
Verma S.B., Madhu R. The steroid-modified tinea. Indian J Dermatol. 2017;62(5): 489–495.
Coondoo A., Phiske M., Verma S., Lahiri K. Side-effects of topical steroids. Indian J Dermatol. 2014;59(5):456–459.
Panda S., Verma S. The menace of topical steroid misuse. Indian J Dermatol. 2018;63(2):101–102.
Rechel B., Mladovsky P., Ingleby D., Mackenbach J.P., McKee M. Migration and health in an increasingly diverse Europe. Lancet. 2011;381(9873):1235–1245.
Wickramage K., Vearey J., Zwi A.B., Robinson C., Knipper M. Migration and health. Lancet. 2018;392(10164):2606–2654.
Aldridge R.W., Nellums L.B., Bartlett S., et al. Global patterns of mortality in international migrants. Lancet. 2018;392(10164):2553–2566.